Table 4

 Mean (SD) scores and results of additional intention-to-treat analyses adjusted for baseline outcomes scores to compare health outcomes in control and intervention groups at 2, 6, and 12 months

Baseline2 months6 months12 months
Control(N = 47)Intervention(N = 45)Control(N = 42)Intervention(N = 42)Fully adjusted difference*(95% CI)p*Control(N = 42)Intervention(N = 42)Fully adjusted difference*(95% CI)p*Control(N = 42)Intervention(N = 42)Fully adjusted difference*(95% CI)p*
*Adjusted for baseline outcome scores (as covariate) and differences in sex, age at leaving full time education, and recent Accident & Emergency attendance or admission.
Primary outcome
Asthma symptom control score (range 0–9, lower  =  better)5.11 (3.00)6.06 (3.11)5.00 (3.08)4.29 (3.26)1.03 (−0.19 to 2.25)0.104.00 (2.91)4.21 (3.50)0.27 (−0.87 to 1.40)0.644.48 (3.00)4.36 (3.50)0.87 (−0.33 to 2.07)0.15
Secondary outcomes
Asthma quality of life score (range 0–2, lower  =  better)1.14 (0.40)1.20 (0.41)1.08 (0.41)1.04 (0.43)0.14 (0.04 to 0.23)0.011.04 (0.40)1.02 (0.45)0.13 (0.03 to 0.23)0.011.02 (0.44)1.01 (0.45)0.13 (0.02 to 0.25)0.03
SF-36 physical function score (range 0–100, higher  =  better)55.33 (26.83)50.85 (31.46)51.67 (28.08)55.71 (33.21)−7.98 (−16.21 to 0.25)0.0655.36 (29.56)52.98 (31.59)−2.53 (−11.65 to 6.59)0.5858.45 (30.01)55.83 (33.98)−4.46 (−12.51 to 3.60)0.27
SF-36 mental health score (range 0–100, higher  =  better)62.49 (22.14)58.81 (23.01)62.57 (21.16)64.86 (22.60)−7.65 (−15.33 to 0.19)0.0566.19 (20.82)66.19 (22.30)−4.50 (−12.21 to 3.20)0.2563.81 (23.90)66.38 (24.36)−8.31 (−17.20 to 0.58)0.07